company background image
A131030 logo

OPTUS Pharmaceutical KOSDAQ:A131030 Stock Report

Last Price

₩5.46k

Market Cap

₩88.2b

7D

-3.5%

1Y

4.0%

Updated

19 Nov, 2024

Data

Company Financials

OPTUS Pharmaceutical Co., Ltd.

KOSDAQ:A131030 Stock Report

Market Cap: ₩88.2b

A131030 Stock Overview

Provides ophthalmic solutions in South Korea. More details

A131030 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends1/6

Rewards

Trading at 85% below our estimate of its fair value

Earnings grew by 35.6% over the past year

Risk Analysis

Earnings have declined by 12.3% per year over past 5 years

Does not have a meaningful market cap (₩88B)


OPTUS Pharmaceutical Co., Ltd. Competitors

Meta Biomed

KOSDAQ:A059210

₩83.1b

Sewoon Medical

KOSDAQ:A100700

₩113.0b

Green Cross Medical Science

KOSDAQ:A142280

₩82.1b

HASS

KOSDAQ:A450330

₩61.4b

Price History & Performance

Summary of all time highs, changes and price drops for OPTUS Pharmaceutical
Historical stock prices
Current Share Price₩5,460.00
52 Week High₩10,430.00
52 Week Low₩4,970.00
Beta0.51
11 Month Change-18.63%
3 Month Change-19.35%
1 Year Change4.00%
33 Year Change-23.53%
5 Year Change-28.63%
Change since IPO2.44%

Recent News & Updates

Benign Growth For OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030) Underpins Stock's 25% Plummet

Nov 14
Benign Growth For OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030) Underpins Stock's 25% Plummet

Investors Could Be Concerned With OPTUS Pharmaceutical's (KOSDAQ:131030) Returns On Capital

Nov 13
Investors Could Be Concerned With OPTUS Pharmaceutical's (KOSDAQ:131030) Returns On Capital

Capital Allocation Trends At OPTUS Pharmaceutical (KOSDAQ:131030) Aren't Ideal

Aug 07
Capital Allocation Trends At OPTUS Pharmaceutical (KOSDAQ:131030) Aren't Ideal

Recent updates

Benign Growth For OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030) Underpins Stock's 25% Plummet

Nov 14
Benign Growth For OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030) Underpins Stock's 25% Plummet

Investors Could Be Concerned With OPTUS Pharmaceutical's (KOSDAQ:131030) Returns On Capital

Nov 13
Investors Could Be Concerned With OPTUS Pharmaceutical's (KOSDAQ:131030) Returns On Capital

Capital Allocation Trends At OPTUS Pharmaceutical (KOSDAQ:131030) Aren't Ideal

Aug 07
Capital Allocation Trends At OPTUS Pharmaceutical (KOSDAQ:131030) Aren't Ideal

There's Reason For Concern Over OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Massive 28% Price Jump

Jun 27
There's Reason For Concern Over OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Massive 28% Price Jump

There's No Escaping OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Muted Earnings Despite A 43% Share Price Rise

Mar 25
There's No Escaping OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Muted Earnings Despite A 43% Share Price Rise

OPTUS Pharmaceutical's (KOSDAQ:131030) Earnings Are Of Questionable Quality

Mar 13
OPTUS Pharmaceutical's (KOSDAQ:131030) Earnings Are Of Questionable Quality

The Returns On Capital At DHP Korea (KOSDAQ:131030) Don't Inspire Confidence

Apr 05
The Returns On Capital At DHP Korea (KOSDAQ:131030) Don't Inspire Confidence

DHP Korea's (KOSDAQ:131030) Problems Go Beyond Weak Profit

Mar 09
DHP Korea's (KOSDAQ:131030) Problems Go Beyond Weak Profit

DHP Korea Co., Ltd.'s (KOSDAQ:131030) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Feb 10
DHP Korea Co., Ltd.'s (KOSDAQ:131030) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

How Much Did DHP Korea's(KOSDAQ:131030) Shareholders Earn From Share Price Movements Over The Last Five Years?

Jan 12
How Much Did DHP Korea's(KOSDAQ:131030) Shareholders Earn From Share Price Movements Over The Last Five Years?

Should We Be Excited About The Trends Of Returns At DHP Korea (KOSDAQ:131030)?

Dec 08
Should We Be Excited About The Trends Of Returns At DHP Korea (KOSDAQ:131030)?

Shareholder Returns

A131030KR Medical EquipmentKR Market
7D-3.5%5.7%-0.7%
1Y4.0%9.9%-4.1%

Return vs Industry: A131030 underperformed the KR Medical Equipment industry which returned 14.9% over the past year.

Return vs Market: A131030 exceeded the KR Market which returned -3.4% over the past year.

Price Volatility

Is A131030's price volatile compared to industry and market?
A131030 volatility
A131030 Average Weekly Movement6.3%
Medical Equipment Industry Average Movement6.8%
Market Average Movement5.6%
10% most volatile stocks in KR Market11.5%
10% least volatile stocks in KR Market2.7%

Stable Share Price: A131030 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A131030's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2002n/aDong-Hwa Hanwww.optuspharm.com

OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name.

OPTUS Pharmaceutical Co., Ltd. Fundamentals Summary

How do OPTUS Pharmaceutical's earnings and revenue compare to its market cap?
A131030 fundamental statistics
Market cap₩88.20b
Earnings (TTM)₩10.25b
Revenue (TTM)₩77.79b

8.6x

P/E Ratio

1.1x

P/S Ratio

Is A131030 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A131030 income statement (TTM)
Revenue₩77.79b
Cost of Revenue₩34.78b
Gross Profit₩43.02b
Other Expenses₩32.77b
Earnings₩10.25b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)634.40
Gross Margin55.30%
Net Profit Margin13.17%
Debt/Equity Ratio0%

How did A131030 perform over the long term?

See historical performance and comparison

Dividends

1.8%

Current Dividend Yield

n/a

Payout Ratio